237 related articles for article (PubMed ID: 33596252)
1. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
Martínez YA; Guo X; Portales-Pérez DP; Rivera G; Castañeda-Delgado JE; García-Pérez CA; Enciso-Moreno JA; Lara-Ramírez EE
PLoS One; 2021; 16(2):e0246901. PubMed ID: 33596252
[TBL] [Abstract][Full Text] [Related]
2. Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans.
Yang CW; Shi ZL
PLoS One; 2021; 16(2):e0246150. PubMed ID: 33534852
[TBL] [Abstract][Full Text] [Related]
3. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU
Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082
[TBL] [Abstract][Full Text] [Related]
4. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
Behloul N; Baha S; Shi R; Meng J
Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
[TBL] [Abstract][Full Text] [Related]
5. The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection.
Santacroce L; Charitos IA; Carretta DM; De Nitto E; Lovero R
J Mol Med (Berl); 2021 Jan; 99(1):93-106. PubMed ID: 33269412
[TBL] [Abstract][Full Text] [Related]
6. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
Akaji K; Konno H
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
[TBL] [Abstract][Full Text] [Related]
7. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
9. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
Front Immunol; 2020; 11():1949. PubMed ID: 32849654
[TBL] [Abstract][Full Text] [Related]
10. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects.
Maldonado LL; Bertelli AM; Kamenetzky L
Sci Rep; 2021 Feb; 11(1):4108. PubMed ID: 33602998
[TBL] [Abstract][Full Text] [Related]
11. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
Zhou N; Bao J; Ning Y
BMC Bioinformatics; 2021 Jan; 22(1):18. PubMed ID: 33413085
[TBL] [Abstract][Full Text] [Related]
12. Overview of lethal human coronaviruses.
Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2.
Kim Y; Jedrzejczak R; Maltseva NI; Wilamowski M; Endres M; Godzik A; Michalska K; Joachimiak A
Protein Sci; 2020 Jul; 29(7):1596-1605. PubMed ID: 32304108
[TBL] [Abstract][Full Text] [Related]
14. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
[TBL] [Abstract][Full Text] [Related]
15. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
16. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Lima LB; Montenegro RC
Int J Biol Macromol; 2021 May; 179():1-19. PubMed ID: 33667553
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.
Di Maria E; Latini A; Borgiani P; Novelli G
Hum Genomics; 2020 Sep; 14(1):30. PubMed ID: 32917282
[TBL] [Abstract][Full Text] [Related]
18. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
Abdelrahman Z; Li M; Wang X
Front Immunol; 2020; 11():552909. PubMed ID: 33013925
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
Ong E; Wong MU; Huffman A; He Y
Front Immunol; 2020; 11():1581. PubMed ID: 32719684
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2.
Hatmal MM; Alshaer W; Al-Hatamleh MAI; Hatmal M; Smadi O; Taha MO; Oweida AJ; Boer JC; Mohamud R; Plebanski M
Cells; 2020 Dec; 9(12):. PubMed ID: 33302501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
